4//SEC Filing
CDK ASSOCIATES, L.L.C. 4
Accession 0000919574-18-004871
CIK 0001634432other
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 5:33 PM ET
Size
12.1 KB
Accession
0000919574-18-004871
Insider Transaction Report
Form 4
CDK ASSOCIATES, L.L.C.
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-23$4.95/sh+20,400$100,980→ 5,464,734 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-20$4.97/sh+21,100$104,795→ 5,444,334 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-19$4.98/sh+14,000$69,747→ 5,423,234 total
CAXTON CORP
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-19$4.98/sh+14,000$69,747→ 5,423,234 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-20$4.97/sh+21,100$104,795→ 5,444,334 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-23$4.95/sh+20,400$100,980→ 5,464,734 total
Kovner Bruce
10% Owner
Transactions
- Purchase
Ordinary Shares, $0.01 par value
2018-07-19$4.98/sh+14,000$69,747→ 5,423,234 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-23$4.95/sh+20,400$100,980→ 5,464,734 total - Purchase
Ordinary Shares, $0.01 par value
2018-07-20$4.97/sh+21,100$104,795→ 5,444,334 total
Footnotes (1)
- [F1]These shares represent (a) 5,169,133 Ordinary Shares that are owned directly by CDK Associates, LLC, which is a reporting person, and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation, the manager of CDK Associates, LLC, and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation; and (b) 295,601 Ordinary Shares beneficially owned by employees of an affiliate of Caxton Corporation and may be deemed to be indirectly beneficially owned by (i) Caxton Corporation and (ii) Bruce Kovner, the chairman and sole shareholder of Caxton Corporation. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Strongbridge Biopharma plc
CIK 0001634432
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001576081
Filing Metadata
- Form type
- 4
- Filed
- Jul 22, 8:00 PM ET
- Accepted
- Jul 23, 5:33 PM ET
- Size
- 12.1 KB